Plasma-Conditioned Liquids as Anticancer Therapies In Vivo: Current State and Future Directions
Plasma-conditioned liquids (PCL) are gaining increasing attention in the medical field, especially in oncology, and translation to the clinics is advancing on a good path. This emerging technology involving cold plasmas has great potential as a therapeutic approach in cancer diseases, as PCL have be...
Main Authors: | Xavi Solé-Martí, Albert Espona-Noguera, Maria-Pau Ginebra, Cristina Canal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/3/452 |
Similar Items
-
Cold Atmospheric Plasma: A New Strategy Based Primarily on Oxidative Stress for Osteosarcoma Therapy
by: Miguel Mateu-Sanz, et al.
Published: (2021-02-01) -
Biomolecules as Model Indicators of In Vitro and In Vivo Cold Plasma Safety
by: Caitlin Heslin, et al.
Published: (2021-01-01) -
Corrigendum: Biomolecules as Model Indicators of In Vitro and In Vivo Cold Plasma Safety
by: Caitlin Heslin, et al.
Published: (2021-04-01) -
Cold Plasma-Treated Ringer’s Saline: A Weapon to Target Osteosarcoma
by: Miguel Mateu-Sanz, et al.
Published: (2020-01-01) -
Current State of Cold Atmospheric Plasma and Cancer‐Immunity Cycle: Therapeutic Relevance and Overcoming Clinical Limitations Using Hydrogels
by: Milica Živanić, et al.
Published: (2023-03-01)